Arbutus Biopharma (ABUS) Other Gross PP&E Adjustments (2016 - 2025)
Arbutus Biopharma (ABUS) has disclosed Other Gross PP&E Adjustments for 16 consecutive years, with $245000.0 as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 98.39% to $245000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $245000.0 through Dec 2025, down 98.39% year-over-year, with the annual reading at $245000.0 for FY2025, 98.39% down from the prior year.
- Other Gross PP&E Adjustments hit $245000.0 in Q4 2025 for Arbutus Biopharma, down from $15.3 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $15.3 million in Q4 2024 to a low of -$2.3 million in Q1 2021.
- Historically, Other Gross PP&E Adjustments has averaged $2.2 million across 5 years, with a median of -$1.5 million in 2023.
- Biggest five-year swings in Other Gross PP&E Adjustments: grew 23.83% in 2024 and later tumbled 98.39% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $13.3 million in 2021, then increased by 6.5% to $14.1 million in 2022, then rose by 7.3% to $15.2 million in 2023, then increased by 0.65% to $15.3 million in 2024, then crashed by 98.39% to $245000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for ABUS at $245000.0 in Q4 2025, $15.3 million in Q4 2024, and -$1.1 million in Q3 2024.